Isolation and identification of specific bacteriophage against enteropathogenic Escherichia coli (EPEC) and in vitro and in vivo characterization of bacteriophage

FEMS Microbiology Letters

Volumn 365, Issue 16, 2018, Pages

  Vahedi, Azadeh ^a   Dallal, Mohammad Mehdi Soltan ^b   Douraghi, Masoumeh ^b   Nikkhahi, Farhad ^b   Rajabi, Zahra ^b   Yousefi, Maryam ^b   Mousavi, Maryam ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TARBIAT MODARES UNIVERSITY   (Iran)

Author keywords

bacteriophage; enteropathogenic Escherichia coli; Escherichia coli; sewage; polymerase chain reaction

Indexed keywords

CIPROFLOXACIN; VEROTOXIN 1; ESCHERICHIA COLI PROTEIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL GENE; BACTERIOPHAGE; BACTERIUM ISOLATION; CELL ADHESION ASSAY; CITROBACTER FREUNDII; CONTROLLED STUDY; ENTEROPATHOGENIC ESCHERICHIA COLI; ESCHERICHIA COLI; FLUORESCENCE MICROSCOPY; HEP-2 CELL LINE; IN VITRO STUDY; IN VIVO STUDY; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; MEDICATION COMPLIANCE; MINIMUM INHIBITORY CONCENTRATION; MTT ASSAY; NONHUMAN; PHAGE THERAPY; PSEUDOMONAS AERUGINOSA; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; SHIGELLA FLEXNERI; TRANSMISSION ELECTRON MICROSCOPY; VIRUS IDENTIFICATION; VIRUS ISOLATION; YERSINIA ENTEROCOLITICA; ANIMAL; BAGG ALBINO MOUSE; CLASSIFICATION; ESCHERICHIA COLI INFECTION; FEMALE; GENETICS; HOST RANGE; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; MOUSE; PHYSIOLOGY; VIROLOGY;

ANIMALS; BACTERIOPHAGES; ENTEROPATHOGENIC ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; FEMALE; HOST SPECIFICITY; HUMANS; MICE; MICE, INBRED BALB C; PHAGE THERAPY;

EID: 85058361831     PISSN: 03781097     EISSN: 15746968     Source Type: Journal    
DOI: 10.1093/femsle/fny136     Document Type: Article

References (27)

1. Alam M, Farzana T, Ahsan CR et al. Distribution of coliphages against four E. coli virotypes in hospital originated sewage sample and a sewage treatment plant in Bangladesh. Indian J Microbiol 2011; 51:188-93.
2. Arenas-Hern andez MMP, Martínez-Laguna Y, Torres AG. Clinical implications of enteroadherent Escherichia coli. Curr Gastroenterol Rep 2012; 14:386-94.
3. Bakhshi B, Eftekhari N, Pourshafie MR. Genetic elements associated with antimicrobial resistance among intestinal bacteria. Jundishapur J Microbiol 2014; 7:1-5.
4. Chhibber S, Kaur S, Kumari S. Therapeutic potential of bacteriophage in treating Klebsiella pneumoniae B5055-mediated lobar pneumonia in mice. J Med Microbiol 2008; 57:1508-13.
5. Clarke SC, Haigh RD, Freestone PPE et al. Virulence of enteropathogenic Escherichia coli, a global pathogen. Clin Microbiol Rev 2003; 16:365-78.
6. Clokie MRJ, Millard AD, Letarov AV et al. Phages in nature. Bacteriophage 2011; 1:31-45.
7. Denou E, Bruttin A, Barretto C et al. T4 phages against Escherichia coli diarrhea: potential and problems. Virology 2009; 388: 21-30.
8. Dini C, Bolla PA, Urraza PJ. Treatment of in vitro enterohemorrhagic Escherichia coli infection using phage and probiotics. J Appl Microbiol 2016; 121:78-88.
9. Dupont A, Sommer F, Zhang K et al. Age-dependent susceptibility to enteropathogenic Escherichia coli (EPEC) infection in mice. PLoS Pathog 2016; 12:1-19.
10. Fagan PK, HornitzkyMA, Bettelheim KA et al. Detection of Shigalike toxin (stx1 and stx2), intimin (eaeA), and enterohemorrhagic Escherichia coli (EHEC) hemolysin (EHEC hlyA) genes in animal feces by multiplex PCR. Appl Environ Microbiol 1999; 65:868-72.
11. Hanlon GW. Bacteriophages: an appraisal of their role in the treatment of bacterial infections. Int J Antimicrob Ag 2007; 30:118-28.
12. Jassim SAA, Limoges RG. Natural solution to antibiotic resistance: bacteriophages 'The Living Drugs'. World J Microb Biot 2014; 30:2153-70.
13. Law RJ, Gur-Arie L, Rosenshine I et al. In vitro and in vivo model systems for studying enteropathogenic Escherichia coli infections. Cold Spring Harb Perspect Med 2013; 3:a009977.
14. Li H, Ma ML, Xie H et al. Biosafety evaluation of bacteriophages for treatment of diarrhea due to intestinal pathogen Escherichia coli 3-2 infection of chickens. World J Microb Biot 2012; 28:1-6.
15. Loc-Carrillo C, Abedon ST. Pros and cons of phage therapy. Bacteriophage 2011; 1:111-4.
16. Nikkhahi F, Dallal MMS, Alimohammadi M et al. Phage therapy: assessment of the efficacy of a bacteriophage isolated in the treatment of salmonellosis induced by Salmonella Enteritidis in mice. Gastroenterol Hepatol Bed Bench 2017; 10:131-36.
17. Nobrega FL, Costa AR, Kluskens LD et al. Revisiting phage therapy: new applications for old resources. Trends Microbiol 2015; 23:185-91.
18. Ochoa TJ, Contreras CA. Enteropathogenic Escherichia coli infection in children. Curr Opin Infect Dis 2011; 24:478-83.
19. Pouillot F, Chomton M, Blois H et al. Efficacy of bacteriophage therapy in experimental sepsis and meningitis caused by a clone O25b: H4-ST131 Escherichia coli strain producing CTXM-15. Antimicrob Agents Ch 2012; 56:3568-75.
20. Shende RK, Hirpurkar SD, Sannat C et al. Isolation and characterization of bacteriophages with lytic activity against common bacterial pathogens. Vet World 2017; 10: 973-8.
21. SouliM, Galani I, Giamarellou H. Emergence of extensively drugresistant and pandrug-resistant Gram-negative bacilli in Europe. Euro Surveill 2008; 13:1-11.
22. Sulakvelidze A, Alavidze Z, Morris JG. Bacteriophage therapy. Antimicrob Agents Ch 2001; 45:649-59.
23. Tafti ZSM, Rahbar M, Eslami P et al. A survey of the epidemiology and antibiotic resistance patterns of enteropathogens isolates in an iranian hospital. Int J Enteric Pathog 2016; 4: 41-44.
24. Tanji Y, Shimada T, Fukudomi H et al. Therapeutic use of phage cocktail for controlling Escherichia coli O157:H7 in gastrointestinal tract of mice. J Biosci Bioeng 2005; 100: 280-7.
25. Torres AG, Zhou X, Kaper JB. Adherence of diarrheagenic Escherichia coli strains to epithelial cells. Infect Immun 2005; 73:18-29.
26. Vulcano AB, Tino-De-Franco M, Amaral JA et al. Oral infection with enteropathogenic Escherichia coli triggers immune response and intestinal histological alterations in mice selected for their minimal acute inflammatory responses. Microbiol Immunol 2014; 58:352-9.
27. Wang G, Clark CG, Rodgers FG. Detection in Escherichia coli of the genes encoding the major virulence factors, the genes defining the O157:H7 serotype, and components of the type 2 shiga toxin family by multiplex PCR. J Clin Microbiol 2002; 40:3613-9.